DEFA14A: BrightSpring Health Services Corrects Director Compensation Disclosure in Proxy Statement

BrightSpring Health Services issued a supplement to its definitive proxy statement to correct errors in the director compensation disclosures.

Summary

• BrightSpring Health Services issued a supplement to its definitive proxy statement, dated May 5, 2025, to correct errors in the narrative and tabular disclosures regarding director compensation.
• The supplement amends and replaces the first two paragraphs under the heading 'Executive Compensation Discussion and Analysis – Director Compensation' on page 38 of the Proxy Statement.
• The corrected disclosure details the cash retainers and annual equity retainers for non-employee directors.
• Non-employee directors receive $100,000 per year for service as a Board member, with additional compensation for committee chairs and members.
• The annual equity retainer is an RSU award with a grant date fair market value of $180,000, cliff-vesting on the first anniversary of the grant date.
• Ms. Kirtley received an additional incremental RSU award during 2024 with a grant date fair value equal to $50,000.
• The supplement includes a table providing information regarding the total compensation earned by or paid to each non-employee director in the fiscal year ended December 31, 2024.

Sentiment

Score: 7

Explanation: The document is a routine correction of a proxy statement, indicating a commitment to accuracy and transparency, which is viewed neutrally to positively.

Positives

• The company is transparently correcting errors in its proxy statement.
• The disclosure provides clear details on director compensation.

Industry Context

Director compensation is a standard disclosure in proxy statements, and this correction ensures compliance and transparency for shareholders.

Comparison to Industry Standards

• Director compensation packages typically include a mix of cash retainers and equity awards.
• The specific amounts vary based on company size, industry, and board responsibilities.
• Comparing BrightSpring's director compensation to similar healthcare service companies would provide a benchmark for competitiveness.
• Companies like Option Care Health (OPCH) and Addus HomeCare (ADUS) could be considered peers for comparison purposes.

Stakeholder Impact

• Shareholders receive corrected information for informed voting decisions.
• The correction ensures transparency and accountability in director compensation.

Next Steps

• Shareholders will consider the corrected information when voting at the Annual Meeting on May 28, 2025.

Key Dates

Keywords

proxy statement, director compensation, BrightSpring Health Services, RSU, cash retainer, governance